Antidiuretic effects of the endothelin receptor antagonist avosentan.
about
Nanomedicines for Endothelial Disorders.Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.Emerging drugs for managing kidney disease in patients with diabetes.Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials.
P2860
Antidiuretic effects of the endothelin receptor antagonist avosentan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@ast
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@en
type
label
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@ast
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@en
prefLabel
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@ast
Antidiuretic effects of the endothelin receptor antagonist avosentan.
@en
P2093
P2860
P356
P1476
Antidiuretic effects of the endothelin receptor antagonist avosentan
@en
P2093
Christian E Zaugg
Christoph Schumacher
Jane F Reckelhoff
Ovidiu Constantin Baltatu
P2860
P356
10.3389/FPHYS.2012.00103
P577
2012-04-18T00:00:00Z